Ledger.Open graph →
SEC Form D · filed April 8, 2020

Regenacy Pharmaceuticals, Inc

Offering
$40.7M
Sold
$20.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WALTHAM, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

John Rocha · Waltham, MAExecSimon Jones · Waltham, MAExec · DirectorShixiang L. Yan · Waltham, MADirectorMarc Cohen · Waltham, MAExec · DirectorMichael L. Huang · Waltham, MADirectorWilliam L. Chin · Waltham, MADirectorDaguang L. Wang · Waltham, MADirectorGarden State Holdings GP, LLC · Norfolk, VADirectorCole J. Van Nice · Pittsburgh, PADirectorTimothy J. Zak · Pittsburgh, PADirectorJames J. Liken · Pittsburgh, PAExec · DirectorGarden State Managing Co. GP, LP · Norfolk, VAExec · DirectorClement J. Handron Iii · Pittsburgh, PADirectorLawrence J. Weidman · Pittsburgh, PAExecAlexander M. Manson · Vancouver, British Columbia, CanadaDirectorThomas Patton · Vancouver, British Columbia, CanadaDirectorJeffrey C. Lightcap · Charleston, SCExec · DirectorMorley Greene · Vancouver, British Columbia, CanadaDirectorRobert D. Perkins · Vancouver, British Columbia, CanadaDirectorKen H. Lai · Vancouver, British Columbia, CanadaExec · DirectorChristian R. Skogen · Vancouver, British Columbia, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗